Mary Dibiase serves as Executive at X4 Pharmaceuticals, Inc, where they oversee executive responsibilities. Since joining the company, Mary Dibiase has executed 18 insider transactions totaling $95.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 9, 2024 involved selling 2,642 shares valued at $1.7K.
Mary Dibiase currently holds 289,110 shares of X4 Pharmaceuticals, Inc (XFOR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mary Dibiase has been a net seller of XFOR stock. They have purchased $0 and sold $95.5K worth of shares.
Mary Dibiase's most recent insider trade was on Sep 9, 2024, when they sold 2,642 shares at $0.66 per share.
Get notified when new Form 4 filings are submitted
| $0.88 |
| Discretionary |
| Feb 12, 2024 | XFOR | $3.7K | Sale | 3,683 | $1.01 | Discretionary |
| Nov 1, 2023 | XFOR | $49.4K | Sale | 67,695 | $0.73 | Planned |
| Oct 31, 2023 | XFOR | $0 | Award | 230,645 | $N/A | Discretionary |
| Sep 8, 2023 | XFOR | $3.3K | Sale | 2,642 | $1.25 | Discretionary |
| Jun 30, 2023 | XFOR | $877 | Sale | 464 | $1.89 | Discretionary |
| Jun 23, 2023 | XFOR | $1.7K | Sale | 857 | $1.93 | Discretionary |
| Jun 15, 2023 | XFOR | $1.9K | Sale | 857 | $2.23 | Discretionary |
| Mar 10, 2023 | XFOR | $15.3K | Sale | 18,192 | $0.84 | Discretionary |
| Feb 13, 2023 | XFOR | $4.0K | Sale | 4,348 | $0.93 | Discretionary |
| Aug 17, 2022 | XFOR | $0 | Sale | 1,713 | $N/A | Discretionary |
| Jun 30, 2022 | XFOR | $0 | Sale | 1,578 | $N/A | Discretionary |
| Jun 24, 2022 | XFOR | $0 | Sale | 856 | $N/A | Discretionary |
| Jun 16, 2022 | XFOR | $0 | Sale | 856 | $N/A | Discretionary |
| Mar 1, 2022 | XFOR | $0 | Award | 105,000 | $N/A | Discretionary |
| Feb 11, 2022 | XFOR | $0 | Sale | 12,545 | $N/A | Discretionary |
| Sep 8, 2021 | XFOR | $0 | Award | 27,000 | $N/A | Discretionary |